Last reviewed · How we verify
ibuprofen intravenous
Ibuprofen intravenous, developed by Rutgers, The State University of New Jersey, is a marketed drug with a key composition patent expiring in 2028. Its primary strength lies in its established market presence and the potential for continued revenue generation until the patent expiry. The primary risk is the loss of exclusivity post-2028, which could lead to increased competition from generic versions.
At a glance
| Generic name | ibuprofen intravenous |
|---|---|
| Also known as | Caldolor |
| Sponsor | Rutgers, The State University of New Jersey |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- ERAS (Enhanced Recovery After Surgery) and Multimodal Analgesia in Laparoscopic Cholecystectomy
- Comparative Assessment of Oral Premedication Regimens in Pediatric Ambulatory Surgery (NA)
- Preemptive IV Ibuprofen for Neurocognitive Recovery and Analgesic Needs After Inguinal Hernia Surgery (PHASE4)
- Postoperative Analgesic Efficacy of SPSIPB in Anterior Cervical Discectomy (NA)
- HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers (PHASE1, PHASE2)
- Comparison of M-TAPA and TAP Blocks on Postoperative Analgesia in Laparoscopic Inguinal Hernia Surgeries (NA)
- Effect of Perioperative IV Ibuprofen on Cerebral Oxygenation and Postoperative Cognition During One-Lung Ventilation (NA)
- The Effect of Multimodal Pain Regimen on Use of Narcotics After Rotator Cuff Tear Repair (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ibuprofen intravenous CI brief — competitive landscape report
- ibuprofen intravenous updates RSS · CI watch RSS
- Rutgers, The State University of New Jersey portfolio CI